Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.

MLA

Qiu, Yu, et al. “Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.” Frontiers in Oncology, vol. 11, Nov. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fonc.2020.01502.

APA

Qiu, Y., Cui, L., Lin, Y., Gao, B., Li, J., Zhao, X., Zhu, X., Hu, S., & Lin, L. (2020). Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology, 11, N.PAG. https://doi.org/10.3389/fonc.2020.01502

Chicago

Qiu, Yu, Li Cui, Yang Lin, Bingju Gao, Jun Li, Xinyuan Zhao, Xiaofeng Zhu, Shen Hu, and Lisong Lin. 2020. “Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.” Frontiers in Oncology 11 (November): N.PAG. doi:10.3389/fonc.2020.01502.